Addressing Unmet Needs: The Future of Parkinson’s Disease Psychosis Treatment Market
Epidemiology Insights and Projection of Parkinson’s Disease Psychosis Parkinson's Disease (PD) is a neurodegenerative disorder that affects millions of people worldwide. It is characterized by the progressive loss of dopamine-producing cells in the brain, leading to motor symptoms such as tremors, stiffness, and bradykinesia. However, a lesser-known complication of PD is Parkinson's Disease Psychosis (PDP) , which affects approximately 50% of patients over the course of their illness. Market Insights and Projections of Parkinson’s Disease Psychosis The market for Parkinson's Disease Psychosis treatment has witnessed significant growth in recent years, driven by the rising prevalence of PD and the increasing recognition of PDP as a debilitating condition. As the population ages, the number of individuals affected by PD is expected to rise, thereby fueling the demand for effective PDP treatments. Parkinson's Psychosis Treatment: Addressing Unmet Needs The current stan